BNTX BioNTech
BioNTech earnings company data as of 7:06 PM ET 10/30
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 0.82 | — | — |
| Rev | $1.04B | — | — |
Insider trades
Open-market buys and sales by BNTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $89.8M sold by 2 insiders under 10b5-1 plans
-
Ugur Sahin CEOPlanned sale$5.9M 63,209 shares at $94.07 100% of stakeTraded Oct 8–9 Filed Oct 9
-
Ugur Sahin CEOPlanned sale$2.3M 24,000 shares at $95.86 28% of stakeTraded Oct 7 Filed Oct 7
-
Ugur Sahin CEOPlanned sale$9M 93,000 shares at $97.14 52% of stakeTraded Oct 5–6 Filed Oct 6
-
Ugur Sahin CEOPlanned sale$3.3M 34,000 shares at $97.09 16% of stakeTraded Oct 1–2 Filed Oct 2
-
Ugur Sahin CEOPlanned sale$6.5M 66,000 shares at $98.19 24% of stakeTraded Sep 29–30 Filed Sep 30
-
Ugur Sahin CEOPlanned sale$6M 61,000 shares at $98.57 18% of stakeTraded Sep 25–28 Filed Sep 28
-
Ugur Sahin CEOPlanned sale$6.8M 69,000 shares at $99.17 17% of stakeTraded Sep 23–24 Filed Sep 24
-
Ugur Sahin CEOPlanned sale$7.9M 79,000 shares at $99.50 16% of stakeTraded Sep 21–22 Filed Sep 22
-
Ugur Sahin CEOPlanned sale$6.2M 64,000 shares at $97.49 12% of stakeTraded Sep 17–18 Filed Sep 18
-
Ugur Sahin CEOPlanned sale$4.7M 49,000 shares at $96.37 8.1% of stakeTraded Sep 15–16 Filed Sep 16
-
Ugur Sahin CEOPlanned sale$8.4M 86,000 shares at $98.13 13% of stakeTraded Sep 11–14 Filed Sep 14
-
Ugur Sahin CEOPlanned sale$2M 20,500 shares at $96.31 2.9% of stakeTraded Sep 10 Filed Sep 11
-
Ugur Sahin CEOPlanned sale$7.2M 73,000 shares at $98.50 9.3% of stakeTraded Sep 8–9 Filed Sep 9
-
Ugur Sahin CEOPlanned sale$7.9M 76,500 shares at $103.12 8.9% of stakeTraded Sep 3–4 Filed Sep 8
-
Sierk Poetting COOPlanned sale$5.5M 50,000 shares at $110.56 11% of stakeTraded Apr 22 Filed Apr 23
SEC filings
Recent issuer filings from EDGAR, 21 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.